Vaneck Pharmaceutical ETF (PPH) closed at $114.41 on October 16, 2026, up 0.3% from the previous close, on volume of 183,591 shares (30-day average 311,915).
Data as of October 16, 2026.
16-Oct-2026
No press releases found.
Mentions of inflation have ballooned for tech companies – SoFi
Seeking Alpha News (Tue, 13-Oct 2:18 PM ET)
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q3
Seeking Alpha News (Tue, 13-Oct 9:35 AM ET)
Healthcare, biotech, pharma are key diversifiers as AI disrupts digital economy – UBS
Seeking Alpha News (Mon, 12-Oct 1:00 PM ET)
The Market Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.
Vaneck Pharmaceutical ETF trades on the NASDAQ stock market under the symbol PPH.
As of October 16, 2026, PPH stock price climbed to $114.41 with 183,591 million shares trading.
PPH has a beta of 0.04, meaning it tends to be less sensitive to market movements. PPH has a correlation of 0.00 to the broad based SPY ETF.
PPH has a market cap of $1.11 billion. This is considered a Small Cap stock.
In the last 3 years, PPH traded as high as $118.00 and as low as $74.05.
PPH has outperformed the market in the last year with a price return of +27.0% while the SPY ETF gained +16.7%. PPH has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +4.4% and +5.9%, respectively, while the SPY returned +1.9% and -0.8%, respectively.
PPH support price is $112.70 and resistance is $115.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PPH shares will trade within this expected range on the day.
